Soluble CD206 and CD163 as novel prognostic biomarkers in adult acute myeloid leukemia

Soluble CD206 and CD163 as novel prognostic biomarkers in adult acute myeloid leukemia

Abstract Background Despite advances in chemotherapy, the prognosis of adult acute myeloid leukemia (AML) patients remains poor, with a 5-year survival rate below 25%. In the tumor microenvironment of AML, tumor-associated macrophages (TAMs) are very important in the microenvironment of AML tumors b...

Full description

Bibliographic Details
Main Authors: Haifa A. Al-Matari, Anwar B. Mansour, Sherif Abdelaziz Ibrahim, Nadia El-Sayed Zaki, Abeer Mahmoud Badr
Format: Article
Language:English
Published: SpringerOpen 2024-11-01
Series:Journal of Basic and Applied Zoology
Subjects:
AML
sCD206
sCD163
Prognostic biomarker
Complete response
Refractory disease
Online Access:https://doi.org/10.1186/s41936-024-00397-3

Internet

https://doi.org/10.1186/s41936-024-00397-3

Similar Items